Steroid shot may buy time for men with tough prostate cancer
NCT ID NCT07161778
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This trial tested a steroid injection called triamcinolone in 55 men with castration resistant prostate cancer, a type that no longer responds to standard hormone therapy. The goal was to see if it could extend the time before chemotherapy is needed, since current steroid treatments only work about 4 months on average. Researchers believe triamcinolone may work differently and avoid resistance seen with other steroids.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
triamcinolone injection
What this could lead to
If it works, this could offer a longer period of disease control before chemotherapy is needed, improving quality of life for older men.
What could go wrong
This is a small, early-phase trial with only 55 participants and no comparison group, so results may not be conclusive. The drug may not improve outcomes or could cause side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CASTRATION-RESISTANT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Raigmore Hospital
Inverness, United Kingdom
-
Royal Sussex County Hospital
Brighton, United Kingdom
-
St Bartholomew's Hospital
London, United Kingdom